Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine Read more about Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA Read more about A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
Apixaban for the Acute Treatment of Venous Thromboembolism in Children Read more about Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study Read more about Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Evaluation of S-600918 in Adults With Refractory Chronic Cough Read more about Evaluation of S-600918 in Adults With Refractory Chronic Cough
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) Read more about A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms Read more about Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
Postop Pain Control in Hip Fracture Surgeyr: Fascia Iliaca Compartment Block Versus Fracture Block Read more about Postop Pain Control in Hip Fracture Surgeyr: Fascia Iliaca Compartment Block Versus Fracture Block
Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care Read more about Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care
Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer Read more about Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer